← Evidence map

ArticleFrontiers in public health2026

Impact of China's national drug price negotiation on pharmaceutical firms' innovation activities.

Heng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42200135